Rheumatoid arthritis (RA) is a common multisystem autoimmune disease. About 0.5% to 1% of the population in Canada lives with RA.
Learn more ➡️ www.cmaj.ca/lookup/doi/10.1503/cmaj.260500
Rheumatoid arthritis (RA) is a common multisystem autoimmune disease. About 0.5% to 1% of the population in Canada lives with RA.
Learn more ➡️ www.cmaj.ca/lookup/doi/10.1503/cmaj.260500
I think when you implant a machine in your neck, you have expectations, even if not immunosuppressive
24mo follow-up RESET-RA VNS device
refractory RA pts
but is ACR20 60% good enough?
(you can add DMARDs on top, though)
ABST1426 #ACR26 RheumNow (on X)
I think when you implant a machine in your neck, you have expectations, even if not immunosuppressive
24mo follow-up RESET-RA VNS device
refractory RA pts
but is ACR20 60% good enough?
(you can add DMARDs on top, though)
ABST1426 #ACR26 RheumNow (on X)
@acr-journals.bsky.social
https://www.rheumatologyadvisor.com/news/dmard-tapering-rheumatoid-arthritis-disease-control/
@acr-journals.bsky.social
https://www.rheumatologyadvisor.com/news/dmard-tapering-rheumatoid-arthritis-disease-control/
ACR Open Rheumatology
doi.org/10.1002/acr2...
ACR Open Rheumatology
doi.org/10.1002/acr2...
GU cancers and RA using VA data - abstracts looking at mortality outcomes
acrabstracts.org/abstract/dis...
acrabstracts.org/abstract/pre...
GU cancers and RA using VA data - abstracts looking at mortality outcomes
acrabstracts.org/abstract/dis...
acrabstracts.org/abstract/pre...
https://www.rheumatologyadvisor.com/news/covid-19-vaccination-outcomes-dmards-biologics/
https://www.rheumatologyadvisor.com/news/covid-19-vaccination-outcomes-dmards-biologics/
27 publications, 5,262 patients (RCTs): tapering raised flare risk (RR 1.56), withdrawal more (RR 2.23), mainly with biologics. Neither cut adverse events.
Zhang, Xu et al. Clin Transl Sci 2026
https://pubmed.ncbi.nlm.nih.gov/42836514/
#MedSky #RheumSky
27 publications, 5,262 patients (RCTs): tapering raised flare risk (RR 1.56), withdrawal more (RR 2.23), mainly with biologics. Neither cut adverse events.
Zhang, Xu et al. Clin Transl Sci 2026
https://pubmed.ncbi.nlm.nih.gov/42836514/
#MedSky #RheumSky
Arthritis & Rheumatology
doi.org/10.1002/art....
Arthritis & Rheumatology
doi.org/10.1002/art....
www.medpagetoday.com/rheumatology...
www.medpagetoday.com/rheumatology...
When treatments succeed, we have to plan the next steps. Let’s remember why we started and set new goals for life after the weight change. buff.ly/cAgYuG1
When treatments succeed, we have to plan the next steps. Let’s remember why we started and set new goals for life after the weight change. buff.ly/cAgYuG1
•Long-Term Osteoporosis Progression With DMARDs
•Baricitinib Response in Lupus Endotypes
•Molecular Endotypes in SLE: CV Risk and LN Insights
→Journal Club: Ixekizumab + Tirzepatide in PsA with overweight or obesity
acrjournals.onlinelibrary.wiley.com/doi/epdf/10....
•Long-Term Osteoporosis Progression With DMARDs
•Baricitinib Response in Lupus Endotypes
•Molecular Endotypes in SLE: CV Risk and LN Insights
→Journal Club: Ixekizumab + Tirzepatide in PsA with overweight or obesity
acrjournals.onlinelibrary.wiley.com/doi/epdf/10....
Enough signal got through to pump me full of IV steroids, transition to 1mg/kg prednisone, taper those while moving to DMARDS/biologics.
Enough signal got through to pump me full of IV steroids, transition to 1mg/kg prednisone, taper those while moving to DMARDS/biologics.
15 September 2026 (Navroze Bureau) : Ongoing measles outbreaks are creating a particular risk for adults living with autoimmune rheumatic diseases, as declining vaccination coverage can leave immunosuppressed patients vulnerable to a highly…
15 September 2026 (Navroze Bureau) : Ongoing measles outbreaks are creating a particular risk for adults living with autoimmune rheumatic diseases, as declining vaccination coverage can leave immunosuppressed patients vulnerable to a highly…